Table 2.
Quantitative Analysis Results of the Vascular and Structure Parameters in Patients With MFS and Normal Controls
| Patients | Control | |
| VD, mm−1 | ||
| Full area | 20.29 ± 2.27 | 21.79 ± 0.99 |
| Central area | 11.56 ± 3.31 | 13.35 ± 2.77 |
| Para | 21.40 ± 2.26 | 22.88 ± 0.95 |
| Inner ring | ||
| Nasal | 21.48 ± 2.59 | 23.03 ± 1.04 |
| Temporal | 21.42 ± 2.46 | 22.71 ± 1.06 |
| Superior | 21.48 ± 2.46 | 22.97 ± 1.15 |
| Inferior | 21.13 ± 2.72 | 22.80 ± 1.30 |
| Perfusion density | ||
| Full area | 0.37 ± 0.04 | 0.38 ± 0.02 |
| Central area | 0.20 ± 0.06 | 0.23 ± 0.05 |
| Para | 0.39 ± 0.07 | 0.40 ± 0.01 |
| Inner ring | ||
| Nasal | 0.39 ± 0.05 | 0.40 ± 0.02 |
| Temporal | 0.39 ± 0.04 | 0.40 ± 0.02 |
| Superior | 0.39 ± 0.04 | 0.41 ± 0.02 |
| Inferior | 0.38 ± 0.05 | 0.40 ± 0.02 |
| FAZ | ||
| Area, mm2 | 0.25 ± 0.08 | 0.21 ± 0.10 |
| Perimeter, mm | 2.20 ± 0.48 | 1.91 ± 0.45 |
| Circularity index | 0.64 ± 0.11 | 0.70 ± 0.08 |
| RNFL, µm | ||
| Average | 98.24 ± 11.98 | 100.94 ± 8.61 |
| Superior | 113.52 ± 23.41 | 124.28 ± 15.32 |
| Inferior | 129.88 ± 18.28 | 128.82 ± 14.95 |
| CMT, µm | 244.54 ± 10.13 | 252.78 ± 14.40 |
| Ganglion cell layer thickness, µm | 80.48 ± 10.86 | 83.29 ± 5.74 |
| Vertical C/D ratio | 0.38 ± 0.17 | 0.41 ± 0.19 |
Data are presented as the mean ± SD.